Alternate Health (CSE:AHG) has announced the transformation of the CanaPass patient management system to complete an ethereum-based blockchain electronic medical records and electronic health records system.

As quoted in the press release:


“Alternate Health’s blockchain EMR/EHR is the first of its kind and completes our comprehensive integration of blockchain technology into all aspects of our software systems,” says Dr. Michael Murphy, Chairman and CEO of Alternate Health. “Along with the deployment of our Zi App Blockchain Mobile Payment System and our CanaPass blockchain transaction ledger, Alternate Health is leading the paradigm shift in emerging healthcare data and medical cannabis technology.”

How the CanaPass Blockchain EMR works:

Based on Ethereum’s platform, CanaPass’ HIPAA and PIPEDA-compliant system records key medical data in blocks on a distributed ledger. Each patient’s CanaPass account includes its own private cryptographic key that is used to identify and decrypt the associated private information from the distributed ledger. This is similar to the way a blockchain wallet works, but instead of keeping track of tokens or digital assets, it is used to track and store data such as the patient’s lab results, medical reports, etc.

Key Advantages of Alternate Health’s Blockchain EMR/EHR:

  • Reliability: The use of decentralized, cloud-based storage ensures maximum reliability and prevents data loss through regular automated backups of all data.
  • Security: All sensitive patient data storage exceeds HIPAA and PIPEDA requirements; Since only the hash value of sensitive data is stored on the blockchain, data can only be decrypted with the private key of that account.
  • Transparency: The use of a distributed ledger ensures data is tamper-proof, preventing cyber-attacks on the system itself since previous transaction data cannot be changed or overwritten.

Click here to read the full press release.

Considering investing in blockchain?

 
Read your free 2020 blockchain outlook report!
 

 

 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less